Maximize Value From
Data
MedAware Systems delivers detailed data, information and analysis from published literature, reported regulatory events and social media. AI-based data & analytics provide comprehensive support for regulatory submissions, post market surveillance, scientific publications, R&D, and other business requirements.
Learn More…
.
AI for Drug Discovery
The cost to develop a new drug can exceed $2.6 billion and take over 15-20 years from drug screening, lab testing, animal studies, Phase 1, Phase 2 and Phase 3 trials and the stringent FDA regulatory process. Biomed AI is a technology platform built to transform the drug discovery and development process using Real World Evidence and artificial intelligence-driven computation.
Learn More…
Real World Evidence
MedAware Systems boasts the most experienced team in medical research data aggregation and analysis in the world. This capability provides you with all available
Clinical Trials Evidence (
CTE) data and
Real World data from Regulatory Databases and Social Media
Learn More…
